2020
DOI: 10.3892/etm.2020.9105
|View full text |Cite
|
Sign up to set email alerts
|

Identification of key differentially expressed mRNAs and microRNAs in non‑small cell lung cancer using bioinformatics analysis

Abstract: Non-small cell lung cancer (NSCLC) is a leading cause of mortality worldwide. However, the pathogenesis of NSCLC remains to be fully elucidated. Therefore, the present study aimed to explore the differential expression of mRNAs and microRNAs (miRNAs/miRs) in NSCLC and to determine how these RNA molecules interact with one another to affect disease progression. Differentially expressed genes (DEGs) and differentially expressed miRNAs (DEMs) were identified from the GSE18842, GSE32863 and GSE29250 datasets downl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 73 publications
0
1
0
Order By: Relevance
“…In recent decades, advanced gene microarrays and high-throughput sequencing methods have been used to study CRC gene expression, therapeutic targets, and pathogenesis [ 11 ]. Analysis of gene expression microarray data with bioinformatics provides an effective tool for identifying previously unknown mRNAs and microRNAs (miRNAs) that may have a role in cancer pathogenesis [ 12 ]. CRC is associated with abnormal gene expression and mutations.…”
Section: Introductionmentioning
confidence: 99%
“…In recent decades, advanced gene microarrays and high-throughput sequencing methods have been used to study CRC gene expression, therapeutic targets, and pathogenesis [ 11 ]. Analysis of gene expression microarray data with bioinformatics provides an effective tool for identifying previously unknown mRNAs and microRNAs (miRNAs) that may have a role in cancer pathogenesis [ 12 ]. CRC is associated with abnormal gene expression and mutations.…”
Section: Introductionmentioning
confidence: 99%